926 related articles for article (PubMed ID: 33710296)
1. COVID-19 vaccination and antirheumatic therapy.
Arnold J; Winthrop K; Emery P
Rheumatology (Oxford); 2021 Aug; 60(8):3496-3502. PubMed ID: 33710296
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
[TBL] [Abstract][Full Text] [Related]
3. A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review.
Soy M; Keser G; Atagunduz P; Mutlu MY; Gunduz A; Koybaşi G; Bes C
Clin Rheumatol; 2021 Sep; 40(9):3533-3545. PubMed ID: 33751280
[TBL] [Abstract][Full Text] [Related]
4. Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination.
Andreica I; Blazquez-Navarro A; Sokolar J; Anft M; Kiltz U; Pfaender S; Vidal Blanco E; Westhoff T; Babel N; Stervbo U; Baraliakos X
RMD Open; 2022 Sep; 8(2):. PubMed ID: 36104115
[TBL] [Abstract][Full Text] [Related]
5. Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases.
Friedman MA; Curtis JR; Winthrop KL
Ann Rheum Dis; 2021 Oct; 80(10):1255-1265. PubMed ID: 34493491
[TBL] [Abstract][Full Text] [Related]
6. Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases.
Spiera R; Jinich S; Jannat-Khah D
Ann Rheum Dis; 2021 Oct; 80(10):1357-1359. PubMed ID: 33975857
[No Abstract] [Full Text] [Related]
7. COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology.
Park JK; Lee EB; Shin K; Sung YK; Kim TH; Kwon SR; Lee MS; Hong SJ; Choi BY; Lee SS; Back HJ;
J Korean Med Sci; 2021 Mar; 36(12):e95. PubMed ID: 33783147
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses.
Saleem B; Ross RL; Bissell LA; Aslam A; Mankia K; Duquenne L; Corsadden D; Carter C; Hughes P; Nadat FA; Mulipa P; Lobb M; Clarke B; Mbara K; Morton R; Dibb S; Chowdhury R; Newton D; Pike A; Kakkar V; Savic S; DelGaldo F; Emery P
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35365569
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccination in our transplant recipients: The time is now.
Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L
J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534
[TBL] [Abstract][Full Text] [Related]
10. Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab.
Benucci M; Damiani A; Infantino M; Manfredi M; Grossi V; Lari B; Gobbi FL; Sarzi-Puttini P
Immunol Res; 2021 Aug; 69(4):309-311. PubMed ID: 34324159
[No Abstract] [Full Text] [Related]
11. Cancer Centers, Organizations Call for COVID-19 Vaccine for Patients With Cancer, Survivors.
Printz C
Cancer; 2021 Apr; 127(8):1170-1171. PubMed ID: 33878201
[No Abstract] [Full Text] [Related]
12. An Open Letter: COVID-19 and Cancer.
Printz C
Cancer; 2021 Apr; 127(8):1171. PubMed ID: 33878202
[No Abstract] [Full Text] [Related]
13. Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults.
Fisher KA; Bloomstone SJ; Walder J; Crawford S; Fouayzi H; Mazor KM
Ann Intern Med; 2020 Dec; 173(12):964-973. PubMed ID: 32886525
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.
Subesinghe S; Bechman K; Rutherford AI; Goldblatt D; Galloway JB
J Rheumatol; 2018 Jun; 45(6):733-744. PubMed ID: 29545454
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for childhood vaccination against COVID-19?
Eberhardt CS; Siegrist CA
Pediatr Allergy Immunol; 2021 Jan; 32(1):9-16. PubMed ID: 33113210
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review.
Atagündüz P; Keser G; Soy M
Front Immunol; 2021; 12():734279. PubMed ID: 35154066
[TBL] [Abstract][Full Text] [Related]
17. What Are COVID-19 Vaccines?
Hartert TV; Sockrider M
Am J Respir Crit Care Med; 2021 May; 203(9):P22-P23. PubMed ID: 33759735
[No Abstract] [Full Text] [Related]
18. One Shot Wonder: A Vaccine Against All Coronaviruses.
Mertz L
IEEE Pulse; 2020; 11(6):2-5. PubMed ID: 33315546
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
20. Effect of DMARDs on the immunogenicity of vaccines.
van Sleen Y; van der Geest KSM; Huckriede ALW; van Baarle D; Brouwer E
Nat Rev Rheumatol; 2023 Sep; 19(9):560-575. PubMed ID: 37438402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
